Tumor biomarkers, such as carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), squamous cell carcinoma associated antigen (SCC), gastrin-releasing peptide precursor (Pro-GRP) and cytokeratin 19 fragment (CYFRA21-1) were normal. The gene discussed is ENO2; the disease is neoplasm.